Adaptive Biotechnologies Corp (ADPT) experienced a significant pre-market plunge of 10.40% on Thursday, as traders reacted ahead of the company's scheduled quarterly earnings report.
The sharp decline comes as the company is set to report its fourth-quarter results later in the day. According to earnings estimates, analysts expect Adaptive Biotechnologies to post a loss of $0.19 per share for the quarter, contributing to negative sentiment in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments